A new study from Stockholm University has overturned the long-held view that the brain's serotonin system responds uniformly to antidepressant drugs. Using spatial transcriptomics, researchers mapped how fluoxetine (Prozac) alters gene activity in the dorsal raphe nucleus—the brain's main serotonin hub—in mice. They discovered two distinct subpopulations of serotonin neurons that react in opposite ways to the same medication.
Led by Assistant Professor Iskra Pollak Dorocic, the team used spatial transcriptomics to read gene expression at single-cell resolution without mixing different neuron types. After short-term fluoxetine treatment, one group of serotonin neurons sharply increased expression of prodynorphin (Pdyn), a neuropeptide linked to stress and depressive symptoms. This transient spike offers a concrete molecular explanation for the heightened anxiety and mood worsening that many patients report during the first days of SSRI therapy.
In contrast, a separate subpopulation responded only to chronic, long-term treatment by ramping up thyrotropin-releasing hormone (TRH), a signaling molecule associated with anti-depressive effects. The timing mirrors the well-known 2–4 week delay before clinical relief appears. "Rather than treating the serotonin system as a single uniform population, we used spatial transcriptomics to see that these neurons are far more diverse and do not all respond the same way," Dorocic explained.
These findings, published in Neuroscience News on June 8, 2026, challenge the traditional serotonin homogeneity fallacy. About 10% of people in nations like Sweden take antidepressants, yet their precise effects on gene expression were poorly understood. Mapping these two pathways provides a blueprint for designing next-generation antidepressants that preserve the delayed TRH benefit while avoiding the initial Pdyn-driven side effects.
For the curious brain trainer, this research underscores a key cognitive principle: biological systems often use opposing forces to fine-tune their function. Just as your brain balances excitation and inhibition, here the same drug triggers antagonistic responses across different neuron populations. Understanding such complexity can deepen your appreciation for why some brain changes take time—and why patience with your own cognitive training may pay off.
What you can do: If you take an SSRI, be aware that initial side effects may stem from a distinct neuronal response that typically fades. Discuss any early discomfort with your doctor; it might be a sign the drug is engaging the right targets. For non-medicated readers, consider how your own brain's subpopulations—like those involved in memory or attention—benefit from consistent, long-term training rather than quick fixes.
Source: Neuroscience News
Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.
